glp 1 bmi 27 Who Qualifies for Semaglutide GLP-1 Injections for Weight Loss? The trillion-dollar GLP-1 fiscal opportunity
Description
The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031
In 2025, more than 30 million Americans turned to GLP-1 injections to regulate their blood sugar, digestion and hunger
But Lilly is hitting a bigger market
As dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists like tirzepatide are increasingly used for weight management ...
Morosil (in the Gummies) supports lipid metabolism
High-protein nutrition meets dessert-level flavor
